Drug-binding hydrogels of hyaluronic acid functionalized with β-cyclodextrin

Journal of Biomedical Materials Research - Part A

Volumn 87, Issue 4, 2008, Pages 1044-1052

  Zawko, Scott A ^a   Truong, Quan ^b   Schmidt, Christine E ^a  

^a The University of Texas at Austin   (United States)

^b The University of Texas at Austin   (United States)

Author keywords

Complex; Cyclodextrin; Hyaluronic acid; Hydrogel; Photopolymerization

Indexed keywords

ACIDS; ADHESION; ADHESIVE JOINTS; BIOLOGICAL MATERIALS; CAPILLARY FLOW; CARBOXYLIC ACIDS; CELL ADHESION; COLLOIDS; DATA STORAGE EQUIPMENT; DRUG DELIVERY; DRUG INTERACTIONS; HYDROPHOBICITY; HYDROXYLATION; MONOMERS; ORGANIC ACIDS; PHOTOPOLYMERIZATION; PHOTORESISTS;

ADAMANTANE; BIOACTIVE DRUGS; BIOMEDICAL APPLICATIONS; COMPLEX; DRUG LOADINGS; FUNCTIONALIZED; HYALURONIC ACID; HYALURONIC ACIDS; HYDROPHOBIC CAVITIES; HYDROPHOBIC DRUGS; HYDROPHOBIC INTERACTIONS; INCLUSION COMPLEXATION; INCLUSION COMPLEXES;

HYDROGELS;

ADAMANTANE; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CARBOXYLIC ACID; HYALURONIC ACID; HYDROCORTISONE; MONOMER;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ADSORPTION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG SYNTHESIS; DRUG UPTAKE; HYDROGEL; HYDROPHILICITY; HYDROPHOBICITY;

BETA-CYCLODEXTRINS; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLUCOCORTICOIDS; HYALURONIC ACID; HYDROCORTISONE; HYDROGELS; METHACRYLATES; MOLECULAR STRUCTURE;

EID: 56749178665     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31845     Document Type: Article

References (37)

1. Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: It's nature, distribution, functions and turnover. J Intern Med 1997;242:27-33.
2. Marshall KW. Intra-articular hyaluronan therapy. Curr Opin Rheumatol 2000;12:468-474.
3. Reijnen MMPJ, Bleichrodt RP, van Goor H. Pathophysiology of intra-abdominal adhesion and abscess formation, and the effect of hyaluronan. Br J Surg 2003;90:533-541.
4. Monheit GD, Coleman KM. Hyaluronic acid fillers. Dermatol Ther 2006;19:141-150.
5. Yoo HS, Lee EA, Yoon JJ, Park TG. Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering. Biomaterials 2005;26:1925-1933.
6. Nettles DL, Vail TP, Morgan MT, Grinstaff MW, Setton LA. Photocrosslinkable hyaluronan as a scaffold for articular cartilage repair. Ann Biomed Eng 2004;32:391-397.
7. Chung C, Mesa J, Miller GJ, Randolph MA, Gill TJ, Burdick JA. Effects of auricular chondrocyte expansion on neocartilage formation in photocrosslinked hyaluronic acid networks. Tissue Eng 2006;12:2665-2673.
8. Park SN, Kim JK, Suh H. Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute. Biomaterials 2004;25:3689-3698.
9. Price RD, Das-Gupta V, Leigh IM, Navsaria HA. A comparison of tissue-engineered hyaluronic acid dermal matrices in a human wound model. Tissue Eng 2006;12:2985-2995.
10. Jia XQ, Burdick JA, Kobler J, Clifton RJ, Rosowski JJ, Zeitels SM, Langer R. Synthesis and characterization of in situ crosslinkable hyaluronic acid-based hydrogels with potential application for vocal fold regeneration. Macromolecules 2004;37:3239-3248.
11. Hemmrich K, von Heimburg D, Rendchen R, Bartolo CD, Milella E, Pallua N. Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials 2005;26:7025-7037.
12. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 2000;50:27-46.
13. Saltzman WM, Olbrich WL. Building drug delivery into tissue engineering. Nat Rev Drug Discov 2002;11:177-186.
14. Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 2001;73:121-136.
15. Payan E, Jouzeau JY, Lapicque F, Bordji K, Simon G, Gillet P, O'Regan M, Netter P. In-vitro drug-release from HYC-141, a corticosteroid ester of high-molecular-weight hyaluronan. J Control Release 1995;34:145-153.
16. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. Controlled chemical modification of hyaluronic acid: synthesis, applications and biodegradation of hydrazide derivatives. J Control Release 1998;53:93-103.
17. Ito T, Fraser IP, Yeo Y, Highley CB, Bellas E, Kohane DS. Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials 2007;28:1778-1786.
18. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech 2005;6:329-357.
19. Uekama K. Design and evaluation of cyclodextrin-based drug formulation. Chem Pharm Bull 2004;52:900-915.
20. Uekama K, Fujinaga T, Hirayama F, Otagiri M, Yamasaki M. Inclusion complexations of steroid-hormones with cyclodextrins in water and in solid-phase. Int J Pharm 1982;10:1-15.
21. Cromwell WC, Bystrom K, Eftink MR. Cyclodextrin adamantanecarboxylate inclusion complexes - Studies of the variation in cavity size. J Phys Chem 1985;89:326-332.
22. The United States Pharmacopeia. The National Formulary. Rockville, MD: The United States Pharmacopeia; 2004.
23. Liu FY, Kildsig DO, Mitra AK. Beta-cyclodextrin steroid complexation - Effect of steroid structure on association equilibria. Pharm Res 1990;7:869-873.
24. Szeman J, Fenyvesi E, Szejtli J, Ueda H, Machida Y, Nagai T. Water-soluble cyclodextrin polymers - Their interaction with drugs. J Inclusion Phenom 1987;5:427-431.
25. Bartsch H, Konig WA, Strassner M, Hintze U. Quantitative determination of native and methylated cyclodextrins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Carbohydr Res 1996;286:41-53.
26. Chankvetadze B, Endresz G, Blaschke G, Juza M, Jakubetz H, Schurig V. Analysis of charged cyclomalto-oligosaccharides (cyclodextrin) derivatives by ion-spray, matrix-assisted laser-desorption/ionization time-of-flight and fast-atom bombardment mass spectrometry, and by capillary electrophoresis. Carbohydr Res 1996;287:139-155.
27. Jacquet R, Favetta P, Elfakir C, Lafosse M. Characterization of a new methylated beta-cyclodextrin with a low degree of substitution by matrix-assisted laser desorption/ionization mass spectrometry and liquid chromatography using evaporative light scattering detection. J Chromatogr A 2005;1083:106-112.
28. Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum 1965;4:117.
29. Leach JB, Bivens KA, Patrick CW Jr, Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003;82:578-589.
30. Brondsted H, Andersen C, Hovgaard L. Crosslinked dextran - A new capsule material for colon targeting of drugs. J Control Release 1998;53:7-13.
31. Buvari-Barcza A, Barcza L. Influence of the guests, the type and degree of substitution on inclusion complex formation of subsituted β-cyclodextrins. Talanta 1999;49:577-585.
32. Davies NM, Wang G, Tucker IG. Evaluation of a hydrocortisone/ hydroxypropyl-beta-cyclodextrin solution for ocular drug delivery. Int J Pharm 1997;156:201-209.
33. Loftsson T, Frioriksdottir H, Sigurdardottir AM, Ueda H. The effect of water-soluble polymers on drug-cyclodextrin complexation. Int J Pharm 1994;110:169-177.
34. Kim SW, Bae YH, Okano T. Hydrogels - Swelling, drug loading, and release. Pharm Res 1992;9:283-290.
35. Hedges AR. Industrial applications of cyclodextrins. Chem Rev 1998;98:2035-2044.
36. Yun YH, Goetz DJ, Yellen P, Chen W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004;25:147-157.
37. Jia X, Yeo Y, Clifton RJ, Jiao T, Kohane DS, Kobler JB, Zeitels SM, Langer R. Hyaluronic acid-based microgels and microgel networks for vocal fold regeneration. Biomacromolecules 2006;7:3336-3344.